Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
While CAR T-cell therapy is currently being explored for pediatric brain tumors like medulloblastoma, most evidence for its effectiveness comes from preclinical studies or…
HPV, especially type 16, drives most oropharyngeal squamous cell carcinomas through E6/E7 oncoproteins, which disable key tumor suppressors and lead to distinct, often more…
Modern radiotherapy protocols for oropharyngeal squamous cell carcinoma have shown improvements in patient-reported outcomes, including fewer symptoms and lower levels of anxiety…
Laparoscopic liver surgery generally offers a faster recovery and fewer complications than open surgery, which can improve quality of life, though long-term survival is similar.
Yes, new combination strategies for liver cancer are emerging, including immunotherapy with anti-angiogenic drugs, and surgical techniques like hepatic vein occlusion with portal…
Yes, hemithyroidectomy is associated with a higher recurrence rate for differentiated thyroid cancer, with a 3% absolute risk increase compared to total thyroidectomy.
TSH suppression therapy is used to control and slow the progression of differentiated thyroid cancer by preventing the hormone from stimulating tumor growth.
Hemithyroidectomy is linked to a slightly higher recurrence risk (about 3% absolute increase) compared to total thyroidectomy, but for low-risk patients the difference is small…
Radioactive iodine therapy for differentiated thyroid cancer commonly causes throat/mouth symptoms, psychological distress, and fatigue, with rare serious side effects like bone…
Yes, a phase IIa trial found becotatug vedotin produced a 20.9% objective response rate in recurrent head and neck squamous cell carcinoma after prior therapy.
Yes, research suggests periodontal disease is linked to a higher risk of pancreatic cancer in older adults, possibly due to chronic inflammation and oral bacteria.
Yes, nivolumab plus ipilimumab provides a 5-year survival benefit for pleural mesothelioma, with 14% vs 6% survival rates compared to chemotherapy.
Serum biomarkers show promise but are not yet accurate enough alone for early oral cancer detection; combining multiple biomarkers improves accuracy.
Yes, adding HITHOC to surgery modestly improves survival for pleural mesothelioma patients without raising early postoperative risk, based on recent meta-analyses.
Yes, immune microenvironment characterization helps identify immune subtypes and biomarkers to guide precision immunotherapy in thyroid cancer, especially for aggressive forms.
Yes, the Systemic Immune-Inflammation Index (SII) can help predict lymph node metastasis in thyroid cancer, with studies showing moderate diagnostic accuracy.
Yes, the Systemic Immune-Inflammation Index (SII) shows moderate diagnostic accuracy for thyroid cancer, with pooled sensitivity of 76.8% and specificity of 71.2% based on a…
Yes, the gut microbiome likely influences thyroid cancer development through immune regulation, hormone metabolism, and metabolite production, though direct evidence in humans is…
Yes, encorafenib plus binimetinib is effective for BRAF V600E-mutated thyroid cancer, with a 54.5% objective response rate in a phase 2 trial, including responses in both…
Yes, chemoimmunotherapy improves survival in patients with liver metastases, with benefits similar to those without liver metastases, according to a large meta-analysis.
Yes, robotic surgery appears safe for treating colorectal cancer and liver metastases together in selected patients, with low conversion rates and no reported deaths in early…
Yes, thermal ablation is a safe and effective treatment for small colorectal liver metastases, with low complication rates and survival outcomes comparable to surgery.
Immune checkpoint inhibitors (ICIs) show reduced effectiveness in patients with liver metastases, but combining them with local treatments or certain targeted therapies may…
Combined pelvic and para-aortic lymphadenectomy may improve survival in intermediate/high-risk endometrial cancer, but evidence is mixed and not definitive for all stages.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.